Semler Scientific Inc (SMLR)vsStryker Corporation (SYK)
SMLR
Semler Scientific Inc
$20.33
0.00%
HEALTHCARE · Cap: $348.27M
SYK
Stryker Corporation
$327.65
-0.26%
HEALTHCARE · Cap: $125.72B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 58339% more annual revenue ($25.12B vs $42.98M). SMLR leads profitability with a 86.2% profit margin vs 12.9%. SMLR trades at a lower P/E of 5.0x. SYK earns a higher WallStSmart Score of 65/100 (C+).
SMLR
Buy53
out of 100
Grade: C-
SYK
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+90.5%
Fair Value
$213.41
Current Price
$20.33
$193.08 discount
Margin of Safety
+16.8%
Fair Value
$393.59
Current Price
$327.65
$65.94 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 86 of every $100 in revenue as profit
Earnings expanding 3570.1% YoY
Earnings expanding 55.9% YoY
Large-cap with strong market position
Strong operational efficiency at 27.2%
Generating 1.9B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Revenue declined 43.2%
Negative free cash flow — burning cash
Operating margin of -25.0%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : SMLR
The strongest argument for SMLR centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 86.2% and operating margin at -25.0%.
Bull Case : SYK
The strongest argument for SYK centers on EPS Growth, Market Cap, Operating Margin. Revenue growth of 11.4% demonstrates continued momentum.
Bear Case : SMLR
The primary concerns for SMLR are Market Cap, Revenue Growth, Free Cash Flow.
Bear Case : SYK
The primary concerns for SYK are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
SMLR profiles as a declining stock while SYK is a value play — different risk/reward profiles.
SMLR carries more volatility with a beta of 1.33 — expect wider price swings.
SYK is growing revenue faster at 11.4% — sustainability is the question.
SYK generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (65/100 vs 53/100) and 11.4% revenue growth. SMLR offers better value entry with a 90.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Semler Scientific Inc
HEALTHCARE · MEDICAL DEVICES · USA
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that help healthcare providers evaluate and treat patients with chronic conditions in the United States. The company is headquartered in Santa Clara, California.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?